Clinical Trial Update: Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HB0017 for efficacy and safety in moderate to severe plaque psoriasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• HB0017

Snippet

Sponsor: Huabo Biopharm Co., Ltd. | Conditions: Psoriasis | Phase 3 | Status: RECRUITING